Showing results (251-260 of 304) with videos related to

Sort By:
Pageof 31
Breast Cancer Research : BCR|April 22, 2024
Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypesJia-Wern Pan, Mohana Ragu, Wei-Qin Chan, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2020
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variantRoshini S Abraham, Joanna M Marshall, Hye Sun Kuehn, et al.
EMBO Molecular Medicine|June 1, 2018
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerDana Wai Yi Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, et al.
European Journal of Medicinal Chemistry|January 7, 2022
Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitorsJulia K Stille, Jevgenijs Tjutrins, Guanyu Wang, et al.
Cancer Research|June 27, 2019
EN1 Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Ashim Subedee, Nicholas W Harper, et al.
EMBO Molecular Medicine|July 22, 2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicityEliana Mc Tacconi, Xianning Lai, Cecilia Folio, et al.
Cell Reports|February 14, 2013
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factorHisham Mohammed, Clive D'Santos, Aurelien A Serandour, et al.
Cancer Cell|June 18, 2014
JARID1B is a luminal lineage-driving oncogene in breast cancerShoji Yamamoto, Zhenhua Wu, Hege G Russnes, et al.
Molecular Oncology|June 2, 2014
Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M A Abdel-Fatah, Roslin Russell, Nada Albarakati, et al.
Pageof 31